Patent 7521198 was granted and assigned to University of Kentucky on April, 2009 by the United States Patent and Trademark Office.
Methods for detecting atherosclerotic plaque and quantifying the amount of Group V sPLA2 in plasma are disclosed. These methods can be used to assess the risk of cardiovascular pathology in a patient.